SAN FRANCISCO – A variety of new, repurposed, and reformulated compounds have made their way into clinical trials for systemic lupus erythematosus, as evidenced by an abstracts session devoted to...

Field of Interest: Rheumatology

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.